Atlas Trials

Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI

Clinical trial NCT04391322 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04391322
Sponsor
The Hospital for Sick Children
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Group 1: Healthy ControlsGroup 2: Stable CFGroup 3: CF Participants Anticipated to Receive CFTR-modulator TherapyGroup 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy
Start date
2020-10-20
Primary completion
2026-06-30
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.